PWID

Population-level estimates of hepatitis C reinfection post scale-up of direct-acting antivirals among people who inject drugs

We estimated HCV reinfection rates among PWID in Scotland pre and post-introduction of DAAs.

Reduction in the population prevalence of HCV viraemia among people who inject drugs associated with scale-up of direct-acting antiviral therapy in community drug services: real world data

We assessed the impact of rapid DAA scale‐up to PWID delivered through community services in the Tayside region of Scotland.

Evaluating the population impact of hepatitis C direct acting antiviral treatment as prevention for people who inject drugs (EPIToPe) – a natural experiment (protocol)

This is a protocol paper for a natural experiment that looks at the population impact of scaling up hepatitis C treatment with direct acting antiviral treatments as a way to prevent disease transmission and reduce prevalence/incidence among people who inject drugs.

Association between universal hepatitis B prison vaccination, vaccine uptake and hepatitis B infection among people who inject drugs

This study examines the impact of the HBV vaccination programme for prisoners in Scotland among people who inject drugs (PWID) in the community

Assessing the impact of a temporary class drug order on ethylphenidate-related infections among people who inject drugs in Lothian, Scotland: an interrupted time-series analysis

In April 2015, the UK government enacted a temporary class drug order (TCDO) on ethylphenidate in response to reported harms associated with its use, in particular an outbreak of infections among people who inject drugs (PWID) in Lothian, Scotland.